PER
Click for more information
1.23% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-23

  1. SRF
    1,046 Posts.
    clock Created with Sketch.
    16/12/11
    16:30
    Post #: 9451867
    Some info on Vitravene and its ISIS connection

    http://www.ott.nih.gov/pdfs/VitraveneCS.pdf


    This precedence clearly illustrates the valuable connection for ANO to have ISIS as partner in Antisense drug deveelopment and in bringing ATL1101 and ATL1103 to FDA approval and commercialisation.
    ANP Price at posting: 27.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.001(1.23%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.